| 标题 |
FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Treatment of Patients with Unresectable or Metastatic, HR-Positive, HER2-Negative Breast Cancer |
| 网址 | |
| DOI |
10.1158/1078-0432.ccr-25-1388
doi
|
| 其它 |
期刊:Clinical Cancer Research 作者:Melanie Royce; Mirat Shah; Lijun Zhang; Joyce Cheng; Mary Kate Bonner; et al 出版日期:2025-08-27 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)